{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:11:39Z","timestamp":1793308299807,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U01-HG006830"],"award-info":[{"award-number":["U01-HG006830"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In over half of pediatric cases, ADHD presents with comorbidities, and often, it is unclear whether the symptoms causing impairment are due to the comorbidity or the underlying ADHD. Comorbid conditions increase the likelihood for a more severe and persistent course and complicate treatment decisions. Therefore, it is highly important to establish an algorithm that identifies ADHD and comorbidities in order to improve research on ADHD using biorepository and other electronic record data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>It is feasible to accurately distinguish between ADHD in isolation from ADHD with comorbidities using an electronic algorithm designed to include other psychiatric disorders. We sought to develop an EHR phenotype algorithm to discriminate cases with ADHD in isolation from cases with ADHD with comorbidities more effectively for efficient future searches in large biorepositories. We developed a multi-source algorithm allowing for a more complete view of the patient\u2019s EHR, leveraging the biobank of the Center for Applied Genomics (CAG) at Children\u2019s Hospital of Philadelphia (CHOP). We mined EHRs from 2009 to 2016 using International Statistical Classification of Diseases and Related Health Problems (ICD) codes, medication history and keywords specific to ADHD, and comorbid psychiatric disorders to facilitate genotype-phenotype correlation efforts. Chart abstractions and behavioral surveys added evidence in support of the psychiatric diagnoses. Most notably, the algorithm did not exclude other psychiatric disorders, as is the case in many previous algorithms. Controls lacked psychiatric and other neurological disorders. Participants enrolled in various CAG studies at CHOP and completed a broad informed consent, including consent for prospective analyses of EHRs. We created and validated an EHR-based algorithm to classify ADHD and comorbid psychiatric status in a pediatric healthcare network to be used in future genetic analyses and discovery-based studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this retrospective case-control study that included data from 51,293 subjects, 5840 ADHD cases were discovered of which 46.1% had ADHD alone and 53.9% had ADHD with psychiatric comorbidities. Our primary study outcome was to examine whether the algorithm could identify and distinguish ADHD exclusive cases from ADHD comorbid cases. The results indicate ICD codes coupled with medication searches revealed the most cases. We discovered ADHD-related keywords did not increase yield. However, we found including ADHD-specific medications increased our number of cases by 21%. Positive predictive values (PPVs) were 95% for ADHD cases and 93% for controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We established a new algorithm and demonstrated the feasibility of the electronic algorithm approach to accurately diagnose ADHD and comorbid conditions, verifying the efficiency of our large biorepository for further genetic discovery-based analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02286817\">NCT02286817<\/jats:ext-link>\n                      . First posted on 10 November 2014. ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02777931\">NCT02777931<\/jats:ext-link>\n                      . First posted on 19 May 2016. ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03006367\">NCT03006367<\/jats:ext-link>\n                      . First posted on 30 December 2016. ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02895906\">NCT02895906<\/jats:ext-link>\n                      . First posted on 12 September 2016.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-022-09447-9","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:02:49Z","timestamp":1654916569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities"],"prefix":"10.1186","volume":"14","author":[{"given":"Isabella","family":"Slaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S.","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank D.","family":"Mentch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5131-2811","authenticated-orcid":false,"given":"Joseph T.","family":"Glessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M. A.","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"2","key":"9447_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","volume":"43","author":"GV Polanczyk","year":"2014","unstructured":"Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 2014;43(2):434\u201342. https:\/\/doi.org\/10.1093\/ije\/dyt261 [published Online First: Epub Date].","journal-title":"Int J Epidemiol"},{"issue":"2","key":"9447_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/15374416.2017.1417860","volume":"47","author":"ML Danielson","year":"2018","unstructured":"Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199\u2013212. https:\/\/doi.org\/10.1080\/15374416.2017.1417860 published Online First: Epub Date.","journal-title":"J Clin Child Adolesc Psychol"},{"key":"9447_CR3","doi-asserted-by":"publisher","unstructured":"Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4). https:\/\/doi.org\/10.1542\/peds.2019-2528 published Online First: Epub Date.","DOI":"10.1542\/peds.2019-2528"},{"key":"9447_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-clinpsy-050817-084917","volume":"14","author":"SP Hinshaw","year":"2018","unstructured":"Hinshaw SP. Attention deficit hyperactivity disorder (ADHD): controversy, developmental mechanisms, and multiple levels of analysis. Annu Rev Clin Psychol. 2018;14:291\u2013316. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050817-084917 published Online First: Epub Date.","journal-title":"Annu Rev Clin Psychol"},{"issue":"4","key":"9447_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12402-015-0171-4","volume":"7","author":"R Heidbreder","year":"2015","unstructured":"Heidbreder R. ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis. Atten Defic Hyperact Disord. 2015;7(4):249\u201369. https:\/\/doi.org\/10.1007\/s12402-015-0171-4 published Online First: Epub Date.","journal-title":"Atten Defic Hyperact Disord"},{"issue":"9","key":"9447_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/DBP.0000000000000109","volume":"35","author":"I Koolwijk","year":"2014","unstructured":"Koolwijk I, Stein DS, Chan E, Powell C, Driscoll K, Barbaresi WJ. \u201cComplex\u201d attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic. J Dev Behav Pediatr. 2014;35(9):591\u20137. https:\/\/doi.org\/10.1097\/DBP.0000000000000109 published Online First: Epub Date.","journal-title":"J Dev Behav Pediatr"},{"issue":"12","key":"9447_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00787-017-1005-z","volume":"26","author":"L Reale","year":"2017","unstructured":"Reale L, Bartoli B, Cartabia M, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2017;26(12):1443\u201357. https:\/\/doi.org\/10.1007\/s00787-017-1005-z published Online First: Epub Date.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"9447_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12402-014-0142-1","volume":"7","author":"CM Jensen","year":"2015","unstructured":"Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit\/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015;7(1):27\u201338. https:\/\/doi.org\/10.1007\/s12402-014-0142-1 published Online First: Epub Date.","journal-title":"Atten Defic Hyperact Disord"},{"issue":"5","key":"9447_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/2168479015599811","volume":"49","author":"J Connolly","year":"2015","unstructured":"Connolly J, Glessner J, Elia J, Hakonarson H. ADHD & pharmacotherapy: past, present and future: a review of the changing landscape of drug therapy for attention deficit hyperactivity disorder. Ther Innov Regulat Sci. 2015;49(5):632.","journal-title":"Ther Innov Regulat Sci"},{"issue":"5","key":"9447_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40272-015-0143-3","volume":"17","author":"DF Connor","year":"2015","unstructured":"Connor DF. Pharmacological management of pediatric patients with comorbid attention-deficit hyperactivity disorder oppositional defiant disorder. Paediatr Drugs. 2015;17(5):361\u201371. https:\/\/doi.org\/10.1007\/s40272-015-0143-3 published Online First: Epub Date.","journal-title":"Paediatr Drugs"},{"issue":"13","key":"9447_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1177\/1087054716672337","volume":"23","author":"SM Gruschow","year":"2019","unstructured":"Gruschow SM, Yerys BE, Power TJ, Durbin DR, Curry AE. Validation of the use of electronic health records for classification of ADHD status. J Atten Disord. 2019;23(13):1647\u201355. https:\/\/doi.org\/10.1177\/1087054716672337 published Online First: Epub Date.","journal-title":"J Atten Disord"},{"issue":"1","key":"9447_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1542\/peds.108.1.71","volume":"108","author":"J Guevara","year":"2001","unstructured":"Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of health care services for children with attention-deficit\/hyperactivity disorder. Pediatrics. 2001;108(1):71\u20138. https:\/\/doi.org\/10.1542\/peds.108.1.71 published Online First: Epub Date.","journal-title":"Pediatrics"},{"issue":"5","key":"9447_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1087054713520616","volume":"21","author":"MF Daley","year":"2017","unstructured":"Daley MF, Newton DA, DeBar L, et al. Accuracy of electronic health record-derived data for the identification of incident ADHD. J Atten Disord. 2017;21(5):416\u201325. https:\/\/doi.org\/10.1177\/1087054713520616 published Online First: Epub Date.","journal-title":"J Atten Disord"},{"key":"9447_CR14","first-page":"274","volume":"2011","author":"M Conway","year":"2011","unstructured":"Conway M, Berg RL, Carrell D, et al. Analyzing the heterogeneity and complexity of electronic health record oriented phenotyping algorithms. AMIA Annu Symp Proc. 2011;2011:274\u201383.","journal-title":"AMIA Annu Symp Proc"},{"issue":"2","key":"9447_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/amiajnl-2013-001935","volume":"21","author":"C Shivade","year":"2014","unstructured":"Shivade C, Raghavan P, Fosler-Lussier E, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc. 2014;21(2):221\u201330. https:\/\/doi.org\/10.1136\/amiajnl-2013-001935 published Online First: Epub Date.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"9447_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/clpt.2010.260","volume":"89","author":"RA Wilke","year":"2011","unstructured":"Wilke RA, Xu H, Denny JC, et al. The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther. 2011;89(3):379\u201386. https:\/\/doi.org\/10.1038\/clpt.2010.260 published Online First: Epub Date.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9447_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1037\/a0026712","volume":"26","author":"RC Gur","year":"2012","unstructured":"Gur RC, Richard J, Calkins ME, et al. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology. 2012;26(2):251\u201365. https:\/\/doi.org\/10.1037\/a0026712 published Online First: Epub Date.","journal-title":"Neuropsychology"},{"key":"9447_CR18","unstructured":"Connolly JJ, Glessner JT, Li D, Sleiman PMA, Hakonarson H. The Center for Applied Genomics at The Children\u2019s Hospital of Philadelphia \u2013 pediatric perspectives on genomic medicine. J Precision Med. 2020;6. https:\/\/www.thejournalofprecisionmedicine.com\/thejournal- of-precision-medicine\/the-center-for-applied-genomics-at-the-childrens-hospital-of-philadelphia-pediatricperspectives-on-genomic-medicine\/."},{"issue":"1","key":"9447_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41467-019-13624-1","volume":"11","author":"YR Li","year":"2020","unstructured":"Li YR, Glessner JT, Coe BP, et al. Rare copy number variants in over 100,000 European ancestry subjects reveal multiple disease associations. Nat Commun. 2020;11(1):255. https:\/\/doi.org\/10.1038\/s41467-019-13624-1 published Online First: Epub Date.","journal-title":"Nat Commun"},{"issue":"6","key":"9447_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jamia\/ocv202","volume":"23","author":"JC Kirby","year":"2016","unstructured":"Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016;23(6):1046\u201352. https:\/\/doi.org\/10.1093\/jamia\/ocv202 published Online First: Epub Date.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"9447_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4338\/ACI-2017-02-RA-0029","volume":"8","author":"RA Bush","year":"2017","unstructured":"Bush RA, Connelly CD, Perez A, Barlow H, Chiang GJ. Extracting autism spectrum disorder data from the electronic health record. Appl Clin Inform. 2017;8(3):731\u201341. https:\/\/doi.org\/10.4338\/ACI-2017-02-RA-0029 published Online First: Epub Date.","journal-title":"Appl Clin Inform"},{"key":"9447_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.npbr.2020.02.002","volume":"36","author":"WM Ingram","year":"2020","unstructured":"Ingram WM, Baker AM, Bauer CR, et al. Defining major depressive disorder cohorts using the EHR: multiple phenotypes based on ICD-9 codes and medication orders. Neurol Psychiatry Brain Res. 2020;36:18\u201326. https:\/\/doi.org\/10.1016\/j.npbr.2020.02.002 published Online First: Epub Date.","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"4","key":"9447_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1176\/appi.ajp.2014.14030423","volume":"172","author":"VM Castro","year":"2015","unstructured":"Castro VM, Minnier J, Murphy SN, et al. Validation of electronic health record phenotyping of bipolar disorder cases and controls. Am J Psychiatry. 2015;172(4):363\u201372. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14030423 published Online First: Epub Date.","journal-title":"Am J Psychiatry"},{"key":"9447_CR24","volume-title":"Pediatrics, learning and developmental disorders, attention-deficit\/hyperactivity disorder (ADD, ADHD)","author":"SB Sulkes","year":"2020","unstructured":"Sulkes SB. Pediatrics, learning and developmental disorders, attention-deficit\/hyperactivity disorder (ADD, ADHD). Whitehouse Station: Merck Sharp & Dohme Corp; 2020."},{"key":"9447_CR25","volume-title":"Pediatrics, Mental disorders in children and adolescents","author":"J Elia","year":"2019","unstructured":"Elia J. Pediatrics, Mental disorders in children and adolescents. Whitehouse Station: Merck Sharp & Dohme Corp; 2019."},{"key":"9447_CR26","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV: fourth edition","author":"APA","year":"1994","unstructured":"APA. Diagnostic and statistical manual of mental disorders: DSM-IV: fourth edition. Washington, DC: American Psychiatric Association; 1994. \u00a91994, 1994"},{"issue":"6","key":"9447_CR27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","volume":"164","author":"G Polanczyk","year":"2007","unstructured":"Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942\u20138. https:\/\/doi.org\/10.1176\/ajp.2007.164.6.942 published Online First: Epub Date.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"9447_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","volume":"56","author":"MTA. A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","year":"1999","unstructured":"MTA. A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073\u201386. https:\/\/doi.org\/10.1001\/archpsyc.56.12.1073 published Online First: Epub Date.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"9447_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/CHI.0b013e31816429d3","volume":"47","author":"J Biederman","year":"2008","unstructured":"Biederman J, Ball SW, Monuteaux MC, et al. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry. 2008;47(4):426\u201334. https:\/\/doi.org\/10.1097\/CHI.0b013e31816429d3 published Online First: Epub Date.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"9447_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0022219412464351","volume":"46","author":"GJ DuPaul","year":"2013","unstructured":"DuPaul GJ, Gormley MJ, Laracy SD. Comorbidity of LD and ADHD: implications of DSM-5 for assessment and treatment. J Learn Disabil. 2013;46(1):43\u201351. https:\/\/doi.org\/10.1177\/0022219412464351 published Online First: Epub Date.","journal-title":"J Learn Disabil"},{"key":"9447_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"D Demontis","year":"2019","unstructured":"Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder. Nat Genet. 2019;51:63\u201375. https:\/\/doi.org\/10.1038\/s41588-018-0269-7.","journal-title":"Nat Genet"},{"key":"9447_CR32","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41386-020-0664-5","volume":"45","author":"P Rovira","year":"2020","unstructured":"Rovira P, Demontis D, S\u00e1nchez-Mora C, et al. Shared genetic background between children and adults with attention deficit\/hyperactivity disorder. Neuropsychopharmacol. 2020;45:1617\u201326. https:\/\/doi.org\/10.1038\/s41386-020-0664-5.","journal-title":"Neuropsychopharmacol."},{"issue":"1","key":"9447_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ng.1013","volume":"44","author":"J Elia","year":"2011","unstructured":"Elia J, Glessner JT, Wang K, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2011;44(1):78\u201384. Published 2011 Dec 4. https:\/\/doi.org\/10.1038\/ng.1013.","journal-title":"Nat Genet"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-022-09447-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:03:08Z","timestamp":1654916588000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-022-09447-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9447"],"URL":"https:\/\/doi.org\/10.1186\/s11689-022-09447-9","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects were recruited through IRB-approved protocols. Participants enrolled in various studies and completed a broad informed consent, including consent for prospective analyses of EHRs. Confidentiality is guarded to address issues of privacy and insurability. Each subject is assigned a study number upon recruitment, using complex algorithms to remove personal identification. Encrypted patient data is integrated into the lab\u2019s custom phenotype browser, where it can be coupled with genotyping and sequencing data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}